Document is current
Any future updates will be listed below
-
Authors
Ruutu, Tapani https://orcid.org/0000-0002-4010-8345
Peczynski, Christophe https://orcid.org/0000-0002-3829-0088
Houhou, Mohamed
Polge, Emmanuelle
Mohty, Mohamad https://orcid.org/0000-0002-7264-808X
Kröger, Nicolaus https://orcid.org/0000-0001-5103-9966
Moiseev, Ivan https://orcid.org/0000-0002-4332-0114
Penack, Olaf https://orcid.org/0000-0003-4876-802X
Salooja, Nina https://orcid.org/0000-0001-5668-9001
Schoemans, Hélène https://orcid.org/0000-0002-7568-8239
Duarte, Rafael F.
Schroeder, Thomas
Passweg, Jakob
Wulf, Gerald G.
Ganser, Arnold
Sica, Simona
Arat, Mutlu https://orcid.org/0000-0003-2039-8557
Salmenniemi, Urpu
Broers, Annoek E. C.
Bourhis, Jean Henri
Rambaldi, Alessandro
Maertens, Johan https://orcid.org/0000-0003-4257-5980
Halaburda, Kazimierz
Zuckerman, Tsila https://orcid.org/0000-0002-6204-977X
Labussière-Wallet, Hélène
Basak, Grzegorz https://orcid.org/0000-0003-3858-8180
Koenecke, Christian https://orcid.org/0000-0001-7025-1735
Perić, Zinaida https://orcid.org/0000-0001-9458-8025
- License Information
-
More Information
Article History
Received: 28 February 2023
Revised: 12 July 2023
Accepted: 26 July 2023
First Online: 12 August 2023
Competing interests
: MM received research support and honoraria for lectures from Amgen, Astellas, BMS, GSK, Janssen, Jazz Pharmaceuticals, Pfizer, Takeda, Oncopeptides, Adaptive, and Sanofi. NK served as consultant and received honoraria from Jazz Pharmaceuticals. OP received research and travel support and served as a member of advisory board of Jazz Pharmaceuticals. HS reports having received personal fees from Incyte, Janssen, Novartis, Sanofi and from the Belgian Hematological Society (BHS), as well as research grants from Novartis and the BHS, both paid to her institution. She has received non-financial support from Gilead, Pfizer, the EBMT (European Society for Blood and Marrow Transplantation) and the CIBMTR (Center for International Bone Marrow Transplantation Research). She has also frequently served as a volunteer for EBMT, CIBMTR and EUPATI. RFD received honoraria as speaker for Jazz Pharmaceuticals. TR, IM, TS, JHB, AR, and GB received honoraria from Jazz Pharmaceuticals. CP, MH, EP, NS, JP, GGW, AG, SS, MA, US, AECB, JM, KH, TZ, HL-W, CK, and ZP declare no competing interests.
